GlassScriptPhysician profile
Nick W Liu
NPI 1174750129
$2,990.33
in general payments reported to CMS, 2019-2025
30 companies · $1,426 in 2025
The $1,426 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $735 · 2020: $67.64 · 2022: $76.93 · 2024: $685 · 2025: $1,426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,110.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $1,242.71 | 2024-2025 | Nanoknife |
| Astellas Pharma US INC | $308.57 | 2019-2020 | |
| Kerecis Limited | $204.98 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Procept Biorobotics Corporation | $149.53 | 2025 | |
| Coloplast Corp | $122.28 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $107.65 | 2024-2025 | Orgovyx |
| Urogen Pharma, INC. | $76.93 | 2022 | |
| Baxter Healthcare | $64.60 | 2019 | |
| Laborie Medical Technologies Corp. | $62.38 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Calyxo, INC. | $57.87 | 2024-2025 | Cvac Aspiration System |
| Boston Scientific Corporation | $53.92 | 2019 | |
| Profound Medical Corp. | $49.40 | 2025 | Tulsa-Pro |
| Tolmar Pharmaceuticals, INC. | $45.92 | 2019 | |
| Intuitive Surgical, INC. | $42.74 | 2019 | |
| Janssen Biotech, INC. | $36.79 | 2019-2025 | Erleada |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $35.40 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $34.01 | 2024-2025 | Adstiladrin |
| Karl Storz Endoscopy-America | $33.21 | 2019 | |
| Cook Medical LLC | $32.57 | 2025 | Litho 150 |
| Astrazeneca Pharmaceuticals LP | $32.28 | 2025 | Lynparza |
| Progenics Pharmaceuticals, INC. | $25.85 | 2025 | |
| Olympus America INC. | $24.07 | 2025 | Itind System |
| Immunitybio, INC. | $22.05 | 2025 | |
| Dendreon Pharmaceuticals LLC | $21.60 | 2019 | |
| Medtronic, INC. | $19.51 | 2025 | Interstim |
| 180 Medical, INC. | $19.13 | 2019 | |
| Csl Behring | $18.56 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.87 | 2020 | |
| Encore Medical, LP | $15.00 | 2019 | |
| Endo USA, INC. | $14.95 | 2025 | Aveed, Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nick Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.